1,029
Participants
Start Date
October 31, 1999
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
Ciprofloxacin
Either as oral suspension, oral tablets or sequential intravenous (IV) - oral therapy or purely IV therapy according to label
Non-quinolone antibiotic
Common used dose and route
New York
The Bronx
New Hyde Park
Havertown
Elverson
Richmond
Norfolk
Morgantown
Durham
Wilmington
Charleston
Snellville
Jacksonville
Pensacola
Fort Walton Beach
Hialeah
Miami
Jupiter
Tampa
Tampa
Mobile
Bardstown
Indianapolis
Springfield
Overland Park
Omaha
Omaha
Fort Smith
Oklahoma City
Oklahoma City
Tulsa
Fort Worth
Benbrook
Temple
Houston
Houston
Austin
El Paso
Centennial
Denver
Idaho Falls
Layton
Las Vegas
Pico Rivera
Long Beach
San Bernardino
Fountain Valley
Corona
San Luis Obispo
Honolulu
Orange
Gainesville
Park Ridge
New Orleans
Boston
Red Wing
Hackensack
Voorhees Township
New York
Stony Brook
Akron
Cleveland
Dayton
Youngstown
Memphis
Galveston
Montreal
Lead Sponsor
Bayer
INDUSTRY